GRI-0124

N/A

Report date: 2023/11/27 17:43:56

Base Information

Drug NameGRI-0124
Drug Alias NameGRI-0124
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGri Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGri Bio Inc
Inactive CompaniesN/A
Active IndicationsCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A